NDC 53002-1129
verapamil hydrochloride 240 mg tablet, film coated, extended release
On the label: RPK Pharmaceuticals, Inc.. It's repackaged: RPK Pharmaceuticals, Inc. rebottles it from Glenmark Pharmaceuticals Inc., USA's NDC 68462-260.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Goa, India | Makes it and tests it | Problems found, fixed voluntarilyJun 30, 2026 · 7 inspections, 1 with FDA action |
Repackaging site
- RPK Pharmaceuticals, Inc., Union City, California, United States · repackages it and relabels it
Recalls
- Mar 15, 2021 · Class II · Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots: 19205584
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Verapamil: every company that makes it
- Form
- tablet, film coated, extended release
- Strength
- 240 mg
- Approval
- ANDA ANDA078906
- On the market since
- Sep 17, 2009
- Package NDCs
53002-1129-0- Official label
- DailyMed (National Library of Medicine), updated Jun 7, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?